Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Liposomal Doxorubicin
The 2025-2030 World Outlook for Liposomal Doxorubicin This study covers the world outlook for liposomal doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Neurological Disorder Drugs
The 2025-2030 World Outlook for Neurological Disorder Drugs This study covers the world outlook for neurological disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Nicotine Addiction Therapeutics
The 2025-2030 World Outlook for Nicotine Addiction Therapeutics This study covers the world outlook for nicotine addiction therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Natural Killer Cell Therapeutics
The 2025-2030 World Outlook for Natural Killer Cell Therapeutics This study covers the world outlook for natural killer cell therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Schizophrenia Therapeutics
The 2025-2030 World Outlook for Schizophrenia Therapeutics This study covers the world outlook for schizophrenia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Neuroprotection Therapeutics
The 2025-2030 World Outlook for Neuroprotection Therapeutics This study covers the world outlook for neuroprotection therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Scleroderma Therapeutics
The 2025-2030 World Outlook for Scleroderma Therapeutics This study covers the world outlook for scleroderma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Sepsis Therapeutics
The 2025-2030 World Outlook for Sepsis Therapeutics This study covers the world outlook for sepsis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms This study covers the world outlook for cloud-based drug discovery platforms across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Localized Scleroderma Diagnostics and Therapeutics
The 2025-2030 World Outlook for Localized Scleroderma Diagnostics and Therapeutics This study covers the world outlook for localized scleroderma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earni ... Read More
-
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics This study covers the world outlook for hormone therapy for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Hospital Infection Therapeutics
The 2025-2030 World Outlook for Hospital Infection Therapeutics This study covers the world outlook for hospital infection therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Schizophrenia Drugs
The 2025-2030 World Outlook for Schizophrenia Drugs This study covers the world outlook for schizophrenia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Lupus Drugs
The 2025-2030 World Outlook for Lupus Drugs This study covers the world outlook for lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Human Microbiome Therapeutics
The 2025-2030 World Outlook for Human Microbiome Therapeutics This study covers the world outlook for human microbiome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Therapeutics
The 2025-2030 World Outlook for Lysosomal Storage Diseases Therapeutics This study covers the world outlook for lysosomal storage diseases therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
The 2025-2030 World Outlook for Colorectal Cancer Drugs This study covers the world outlook for colorectal cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments This study covers the world outlook for alpha-1 antitrypsin deficiency treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Orphan Cancer Drugs
The 2025-2030 World Outlook for Orphan Cancer Drugs This study covers the world outlook for orphan cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumors
The 2025-2030 World Outlook for Neuroendocrine Tumors This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for CNS Therapeutics
The 2025-2030 World Outlook for CNS Therapeutics This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Alopecia Drugs
The 2025-2030 World Outlook for Alopecia Drugs This study covers the world outlook for alopecia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Melanoma Therapeutics
The 2025-2030 World Outlook for Melanoma Therapeutics This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments This study covers the world outlook for disease-specific chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More
-
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
Research Assistance
